Literature DB >> 2182676

Culture confirmation of Escherichia coli serotype O157:H7 by direct immunofluorescence.

D L Tison1.   

Abstract

An evaluation of a fluorescein-labeled, polyclonal, affinity-purified goat antibody to Escherichia coli serotype O157:H7 (Kirkegaard & Perry Laboratories Inc., Gaithersburg, Md.) was conducted to determine the efficacy of this research reagent for the rapid direct immunofluorescence identification of E. coli O157:H7 isolated from fecal specimens cultured on sorbitol-MacConkey (SMAC) agar. The E. coli O157:H7 fluorescent-antibody conjugate proved to be 100% sensitive and specific for the rapid identification of non-sorbitol-fermenting E. coli O157:H7 from SMAC agar inoculated with fecal specimens. The addition of SMAC agar to the battery of primary isolation media routinely used for fecal specimens resulted in the identification of 16 patients with E. coli O157:H7 disease from a total of 799 fecal specimens cultured during 1988.

Entities:  

Mesh:

Year:  1990        PMID: 2182676      PMCID: PMC269675          DOI: 10.1128/jcm.28.3.612-613.1990

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  14 in total

1.  Further evidence associating hemolytic uremic syndrome with infection by Verotoxin-producing Escherichia coli O157:H7.

Authors:  W R Gransden; M A Damm; J D Anderson; J E Carter; H Lior
Journal:  J Infect Dis       Date:  1986-09       Impact factor: 5.226

2.  Latex agglutination test for detection of Escherichia coli serotype O157.

Authors:  S B March; S Ratnam
Journal:  J Clin Microbiol       Date:  1989-07       Impact factor: 5.948

3.  H7 antiserum-sorbitol fermentation medium: a single tube screening medium for detecting Escherichia coli O157:H7 associated with hemorrhagic colitis.

Authors:  J J Farmer; B R Davis
Journal:  J Clin Microbiol       Date:  1985-10       Impact factor: 5.948

4.  Unusual verotoxin-producing Escherichia coli associated with hemorrhagic colitis.

Authors:  C A Bopp; K D Greene; F P Downes; E G Sowers; J G Wells; I K Wachsmuth
Journal:  J Clin Microbiol       Date:  1987-08       Impact factor: 5.948

5.  Escherichia coli O157:H7, an emerging gastrointestinal pathogen. Results of a one-year, prospective, population-based study.

Authors:  K L MacDonald; M J O'Leary; M L Cohen; P Norris; J G Wells; E Noll; J M Kobayashi; P A Blake
Journal:  JAMA       Date:  1988-06-24       Impact factor: 56.272

6.  Escherichia coli O157:H7 strains associated with haemorrhagic colitis in the United States produce a Shigella dysenteriae 1 (SHIGA) like cytotoxin.

Authors:  A O O'Brien; T A Lively; M E Chen; S W Rothman; S B Formal
Journal:  Lancet       Date:  1983-03-26       Impact factor: 79.321

7.  Escherichia coli O157:H7 as the predominant pathogen associated with the hemolytic uremic syndrome: a prospective study in the Pacific Northwest.

Authors:  M A Neill; P I Tarr; C R Clausen; D L Christie; R O Hickman
Journal:  Pediatrics       Date:  1987-07       Impact factor: 7.124

8.  Hemorrhagic colitis associated with a rare Escherichia coli serotype.

Authors:  L W Riley; R S Remis; S D Helgerson; H B McGee; J G Wells; B R Davis; R J Hebert; E S Olcott; L M Johnson; N T Hargrett; P A Blake; M L Cohen
Journal:  N Engl J Med       Date:  1983-03-24       Impact factor: 91.245

9.  The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli.

Authors:  M A Karmali; M Petric; C Lim; P C Fleming; G S Arbus; H Lior
Journal:  J Infect Dis       Date:  1985-05       Impact factor: 5.226

10.  Laboratory investigation of hemorrhagic colitis outbreaks associated with a rare Escherichia coli serotype.

Authors:  J G Wells; B R Davis; I K Wachsmuth; L W Riley; R S Remis; R Sokolow; G K Morris
Journal:  J Clin Microbiol       Date:  1983-09       Impact factor: 5.948

View more
  4 in total

1.  Verocytotoxin producing Escherichia coli.

Authors:  M G Brook; B A Bannister
Journal:  BMJ       Date:  1991-10-05

2.  Humoral immune responses to Shiga-like toxins and Escherichia coli O157 lipopolysaccharide in hemolytic-uremic syndrome patients and healthy subjects.

Authors:  J S Greatorex; G M Thorne
Journal:  J Clin Microbiol       Date:  1994-05       Impact factor: 5.948

3.  Immunomagnetic-electrochemiluminescent detection of Escherichia coli O157 and Salmonella typhimurium in foods and environmental water samples.

Authors:  H Yu; J G Bruno
Journal:  Appl Environ Microbiol       Date:  1996-02       Impact factor: 4.792

4.  Monoclonal antibodies for detection of the H7 antigen of Escherichia coli.

Authors:  Y He; J E Keen; R B Westerman; E T Littledike; J Kwang
Journal:  Appl Environ Microbiol       Date:  1996-09       Impact factor: 4.792

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.